Computational Identification of Uncharacterized Cruzain Binding Sites

Chagas disease, caused by the unicellular parasite Trypanosoma cruzi, claims 50,000 lives annually and is the leading cause of infectious myocarditis in the world. As current antichagastic therapies like nifurtimox and benznidazole are highly toxic, ineffective at parasite eradication, and subject to increasing resistance, novel therapeutics are urgently needed. Cruzain, the major cysteine protease of Trypanosoma cruzi, is one attractive drug target. In the current work, molecular dynamics simulations and a sequence alignment of a non-redundant, unbiased set of peptidase C1 family members are used to identify uncharacterized cruzain binding sites. The two sites identified may serve as targets for future pharmacological intervention.

Keränen, HenrikUppsala universitet,Institutionen för cell- och molekylärbiologi(Swepub:uu)henke383 (författare)
Wilson, Benjamin A. (författare)
McCammon, J. Andrew (författare)
Uppsala universitetInstitutionen för cell- och molekylärbiologi (creator_code:org_t)

Ingår i:PLoS Neglected Tropical Diseases: Public Library of Science (PLoS)4:5, s. e676-1935-27271935-2735

Av författaren/redakt...: Durrant, Jacob D ...; Keränen, Henrik; Wilson, Benjamin ...; McCammon, J. And ...

Om ämnet

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.